Startup · $9.9m raised · Healthcare
Developer of Neonav, a vascular device to help clinicians insert catheters into veins of critically ill newborns and children.
Melbourne, VIC
Every investor coverage indicates participated in a round Navi Medical Technologies raised.
| Investor | Rounds | Invested |
|---|---|---|
| Artesian VC | Seed · Grant | - |
| Breakthrough Victoria | Seed · Grant | $1,400,000 |
| Federal Government | Grant | - |
| Innovation (formerly Breakthrough) Victoria | Unnamed stage | - |
| Innovation Victoria | Unnamed stage | - |
| KP Rx | Unnamed stage | $4,000,000 |
| Medtech Actuator | Seed · Grant | - |
| Pacific Chan | Unnamed stage | - |
| Pacific Channel | Unnamed stage | - |
| Victorian government fund | Seed | - |
Companies Navi Medical Technologies acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Navi Medical Technologies. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Roundup of eight Australian and New Zealand startups whose late-July funding totals $102 million across space capsules, medical devices, livestock breath analysis, sports analytics and AI crop forecasting.
Melbourne paediatric device maker Navi Medical Technologies has banked $6.8 million, led by KP Rx, to take its Neonav catheter tool into the US market following regulatory clearance.
Also navitechnologies.com·meditechtoday.com·PR Newswire·SmartCompany·raising.fi·Startup Daily·bushletter.com
Breakthrough Victoria announces it made follow-on investments in four portfolio companies during 2025-26 — Number 8 Bio, Navi Medical Technologies, Liquid Instruments and Type One Energy — to support their growth and commercialisation.
Breakthrough Victoria rounds up April–May 2026 portfolio news, including grants for Number 8 Bio and Xefco, Liquid Instruments' Series C, program selections, partnerships, regulatory clearances and two new Aravax directors.
Wholesale Investor's Steve Torso highlights Australian life sciences companies from the Emergence Preview Series, noting government grant funding, a Series A extension, venture co-investment, and a medtech company's ASX listing.
Also Wholesale Investor
Breakthrough Victoria highlights portfolio achievements including Amber Electric's forty-five million dollar raise, Bygen and Diag-Nose grants, and Quantum Brilliance series A funding.
Also Breakthrough Victoria·Breakthrough Victoria·RenewEconomy·Startup Daily·RenewEconomy·Dealroom
Breakthrough Victoria's CEO reviews its 2024/25 year: growing capital base, strong co-investment leverage, portfolio milestones including Amber's $10m raise, first fellows awarded, and projected economic impact ahead.
Breakthrough Victoria highlights recent achievements of portfolio companies including funding, awards, and expansions for firms like Liquid Instruments, Quantum Brilliance, and Samsara Eco.
Navi Medical Technologies gained US FDA clearance for its Neonav catheter guidance system; the Melbourne firm, backed by Breakthrough Victoria, plans a capital raise later in 2025 to fund its American rollout.
ANDHealth announced its fourth accelerator cohort, granting non-dilutive MRFF funding to six digital health startups including Cape Bionics and Healthily to support commercialisation.
MedTech Actuator alumni are behind Synthesis Capital, a new venture fund courting investors for up to $100m to back young health technology companies across Australia and the Asia-Pacific.
Weekly roundup reporting eight Australian startups together raised $85.6 million across mining tech, cybersecurity, waste, energy storage, health and micromobility, plus a Google.org grant for Global Sisters.
Melbourne medtech Navi Medical Technologies has raised $2.4 million to develop its device guiding catheter placement in newborns, led by Breakthrough Victoria with Medtech Actuator and Artesian VC also participating.
Breakthrough Victoria is putting $700,000 into Navi Medical Technologies' round alongside Medtech Actuator and Artesian VC, helping the Melbourne medtech develop its newborn catheter guidance device toward regulatory approval.